Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-005930
Filing Date
2022-02-01
Accepted
2022-02-01 16:45:07
Documents
2
Period of Report
2022-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1650
2 POA DOCUMENT poa.txt EX-24 3886
  Complete submission text file 0001209191-22-005930.txt   6886
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Issuer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ANIKA THERAPEUTICS, INC. 32 BEDFORD MA 01730
Business Address
Loerop James (Reporting) CIK: 0001781549 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37581 | Film No.: 22579495